ESTIMATION OF USING MEDICATIONS OF DIFFERENT GROUPS FOR COMMUNITY-ACQUIRED PNEUMONIA TREATMENT OF PATIENTS WITH COMORBIDITIES
With purpose to assess the volume and rationality of prescription of medicines for the community-acquired pneumonia (CAP) treatment in patients with chronic comorbidities a prospective study of 438 in-patients (214 men (48.9%), average age - 56,1 ± 17,9) was conducted. Chronic comorbidities were in...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Poltava State Medical University
2017-03-01
|
| Series: | Проблеми екології та медицини |
| Subjects: | |
| Online Access: | https://ecomed-journal.org/index.php/journal/article/view/51 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832549629279862784 |
|---|---|
| author | A.V. Demchuk |
| author_facet | A.V. Demchuk |
| author_sort | A.V. Demchuk |
| collection | DOAJ |
| description | With purpose to assess the volume and rationality of prescription of medicines for the community-acquired pneumonia (CAP) treatment in patients with chronic comorbidities a prospective study of 438 in-patients (214 men (48.9%), average age - 56,1 ± 17,9) was conducted. Chronic comorbidities were in 359 (82.0%) patients. Controlled comorbidities were in 115 (26.3%), uncontrolled - 120 (27.4%), complicated chronic diseases - 124 (28.3%). Comorbidities were absent in 79 (18.0%) patients. There were significant polypharmacy of CAP patients, mean amount of medicines was 11,0 ± 4,0. Complicated chronic diseases in patients with CAP caused prescription of 13,7 ± 5,0 drugs. CAP in-patients with uncontrolled chronic diseases received 11,0 ± 2,9 medicines. CAP in-patients with controlled comorbidities used 9,7 ± 2,7 medicines and patients without comorbidity treated with 8,4 ± 2,5 drugs (p <0.001). All patients received antibiotics, as mandatory CAP treatment. Mucolytics were prescribed 92.7%, dextrans solutions - 36.0%, which was necessary due to features of CAP course. NSAIDs were administered 48.6% patients, but half of them did not need use these medications. Using sulfocamphocaine (39.0%), thiotriazoline (25.1%) and plasmol (13.2%) did not have any positive effect at the clinical course and outcome of CAP, it was mistaken. |
| format | Article |
| id | doaj-art-0a63b16a97424f6e90a3467d58fe5052 |
| institution | Kabale University |
| issn | 2073-4662 2519-2302 |
| language | English |
| publishDate | 2017-03-01 |
| publisher | Poltava State Medical University |
| record_format | Article |
| series | Проблеми екології та медицини |
| spelling | doaj-art-0a63b16a97424f6e90a3467d58fe50522025-02-03T06:10:13ZengPoltava State Medical UniversityПроблеми екології та медицини2073-46622519-23022017-03-01193-4444851ESTIMATION OF USING MEDICATIONS OF DIFFERENT GROUPS FOR COMMUNITY-ACQUIRED PNEUMONIA TREATMENT OF PATIENTS WITH COMORBIDITIESA.V. Demchuk0Vinnytsia National Pirogov Memorial Medical UniversityWith purpose to assess the volume and rationality of prescription of medicines for the community-acquired pneumonia (CAP) treatment in patients with chronic comorbidities a prospective study of 438 in-patients (214 men (48.9%), average age - 56,1 ± 17,9) was conducted. Chronic comorbidities were in 359 (82.0%) patients. Controlled comorbidities were in 115 (26.3%), uncontrolled - 120 (27.4%), complicated chronic diseases - 124 (28.3%). Comorbidities were absent in 79 (18.0%) patients. There were significant polypharmacy of CAP patients, mean amount of medicines was 11,0 ± 4,0. Complicated chronic diseases in patients with CAP caused prescription of 13,7 ± 5,0 drugs. CAP in-patients with uncontrolled chronic diseases received 11,0 ± 2,9 medicines. CAP in-patients with controlled comorbidities used 9,7 ± 2,7 medicines and patients without comorbidity treated with 8,4 ± 2,5 drugs (p <0.001). All patients received antibiotics, as mandatory CAP treatment. Mucolytics were prescribed 92.7%, dextrans solutions - 36.0%, which was necessary due to features of CAP course. NSAIDs were administered 48.6% patients, but half of them did not need use these medications. Using sulfocamphocaine (39.0%), thiotriazoline (25.1%) and plasmol (13.2%) did not have any positive effect at the clinical course and outcome of CAP, it was mistaken.https://ecomed-journal.org/index.php/journal/article/view/51the community-acquired pneumonia, treatment, chronic comorbidities |
| spellingShingle | A.V. Demchuk ESTIMATION OF USING MEDICATIONS OF DIFFERENT GROUPS FOR COMMUNITY-ACQUIRED PNEUMONIA TREATMENT OF PATIENTS WITH COMORBIDITIES Проблеми екології та медицини the community-acquired pneumonia, treatment, chronic comorbidities |
| title | ESTIMATION OF USING MEDICATIONS OF DIFFERENT GROUPS FOR COMMUNITY-ACQUIRED PNEUMONIA TREATMENT OF PATIENTS WITH COMORBIDITIES |
| title_full | ESTIMATION OF USING MEDICATIONS OF DIFFERENT GROUPS FOR COMMUNITY-ACQUIRED PNEUMONIA TREATMENT OF PATIENTS WITH COMORBIDITIES |
| title_fullStr | ESTIMATION OF USING MEDICATIONS OF DIFFERENT GROUPS FOR COMMUNITY-ACQUIRED PNEUMONIA TREATMENT OF PATIENTS WITH COMORBIDITIES |
| title_full_unstemmed | ESTIMATION OF USING MEDICATIONS OF DIFFERENT GROUPS FOR COMMUNITY-ACQUIRED PNEUMONIA TREATMENT OF PATIENTS WITH COMORBIDITIES |
| title_short | ESTIMATION OF USING MEDICATIONS OF DIFFERENT GROUPS FOR COMMUNITY-ACQUIRED PNEUMONIA TREATMENT OF PATIENTS WITH COMORBIDITIES |
| title_sort | estimation of using medications of different groups for community acquired pneumonia treatment of patients with comorbidities |
| topic | the community-acquired pneumonia, treatment, chronic comorbidities |
| url | https://ecomed-journal.org/index.php/journal/article/view/51 |
| work_keys_str_mv | AT avdemchuk estimationofusingmedicationsofdifferentgroupsforcommunityacquiredpneumoniatreatmentofpatientswithcomorbidities |